The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Moderate alcohol use in fatty liver disease; don
Gow P1,2, Testro AG1,2, Hey P1,2, Sinclair M1,2. Hepatology. 2019 Nov 29. doi: 10.1002/hep.31049. [Epub ahead of print]
Author information
1 Liver Transplant Unit, Austin Health, Victoria, Australia.
2 The University of Melbourne, Victoria, Australia.
Abstract
We congratulate Dr Aberg and colleagues for a significant contribution to the literature on the important topic of moderate alcohol use in fatty liver disease (NAFLD) (1). Approximately 30% of the population of the Western world has obesity and/or other complications of insulin resistance and the metabolic syndrome. Due to the magnitude of this problem worldwide, palatable lifestyle therapies that are affordable, available and acceptable are necessary to curtail preventable early deaths. Moderate alcohol has the potential to fill this space, although knowledge remains limited.